Mark Pasanen

614 total citations
9 papers, 395 citations indexed

About

Mark Pasanen is a scholar working on Anesthesiology and Pain Medicine, Pharmacology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Mark Pasanen has authored 9 papers receiving a total of 395 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Anesthesiology and Pain Medicine, 4 papers in Pharmacology and 3 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Mark Pasanen's work include Pain Management and Opioid Use (5 papers), Musculoskeletal pain and rehabilitation (4 papers) and Opioid Use Disorder Treatment (3 papers). Mark Pasanen is often cited by papers focused on Pain Management and Opioid Use (5 papers), Musculoskeletal pain and rehabilitation (4 papers) and Opioid Use Disorder Treatment (3 papers). Mark Pasanen collaborates with scholars based in United States. Mark Pasanen's co-authors include James Kurz, Lisa J. Staton, Eric I. Rosenberg, Ian Chen, Inginia Genao, Alex J. Mechaber, Mukta Panda, Sam Cykert, Diane Calleson and Charles Faselis and has published in prestigious journals such as Journal of General Internal Medicine, Academic Medicine and The American Journal of the Medical Sciences.

In The Last Decade

Mark Pasanen

9 papers receiving 387 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark Pasanen United States 7 172 127 115 75 56 9 395
James Kurz United States 7 189 1.1× 126 1.0× 117 1.0× 78 1.0× 54 1.0× 9 511
Jane O’Rorke United States 7 181 1.1× 139 1.1× 134 1.2× 78 1.0× 55 1.0× 10 415
Leila Z. Islam United States 6 178 1.0× 52 0.4× 120 1.0× 77 1.0× 19 0.3× 11 447
Jacqueline Gardner‐Nix Canada 9 145 0.8× 173 1.4× 161 1.4× 69 0.9× 24 0.4× 11 410
Elspeth E. Shipton New Zealand 7 159 0.9× 100 0.8× 89 0.8× 76 1.0× 13 0.2× 10 397
Andreas Köpf Germany 16 199 1.2× 166 1.3× 138 1.2× 102 1.4× 23 0.4× 43 707
Donna Kalauokalani United States 10 124 0.7× 122 1.0× 112 1.0× 106 1.4× 45 0.8× 16 490
Liliane Mendonça Portugal 9 66 0.4× 113 0.9× 260 2.3× 67 0.9× 19 0.3× 22 434
Joey Ton Canada 8 85 0.5× 36 0.3× 156 1.4× 47 0.6× 15 0.3× 27 285
Beth DeRonne United States 7 381 2.2× 270 2.1× 331 2.9× 78 1.0× 22 0.4× 12 697

Countries citing papers authored by Mark Pasanen

Since Specialization
Citations

This map shows the geographic impact of Mark Pasanen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Pasanen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Pasanen more than expected).

Fields of papers citing papers by Mark Pasanen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Pasanen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Pasanen. The network helps show where Mark Pasanen may publish in the future.

Co-authorship network of co-authors of Mark Pasanen

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Pasanen. A scholar is included among the top collaborators of Mark Pasanen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Pasanen. Mark Pasanen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Staton, Lisa J., Inginia Genao, Mukta Panda, et al.. (2021). When race matters: disagreement in pain perception between patients and their physicians in primary care.. PubMed. 99(5). 532–8. 52 indexed citations
2.
Kennedy, Amanda G., et al.. (2020). A New Quality Improvement Toolkit to Improve Opioid Prescribing in Primary Care. The Journal of the American Board of Family Medicine. 33(1). 17–26. 5 indexed citations
3.
Repp, Allen B, et al.. (2017). What the “Nonteaching” Service Can Teach Us. Academic Medicine. 93(1). 41–44. 6 indexed citations
4.
Pasanen, Mark. (2015). Guillain-Barré Syndrome. 4(2). 177–190. 4 indexed citations
5.
Pasanen, Mark. (2014). Evaluation and Treatment of Colonic Symptoms. Medical Clinics of North America. 98(3). 529–547. 6 indexed citations
6.
Rosenberg, Eric I., Inginia Genao, Ian Chen, et al.. (2008). Complementary and Alternative Medicine Use by Primary Care Patients with Chronic Pain. Pain Medicine. 9(8). 1065–1072. 104 indexed citations
7.
Panda, Mukta, Lisa J. Staton, Ian Chen, et al.. (2006). The Influence of Discordance in Pain Assessment on the Functional Status of Patients with Chronic Nonmalignant Pain. The American Journal of the Medical Sciences. 332(1). 18–23. 14 indexed citations
8.
Chen, Ian, James Kurz, Mark Pasanen, et al.. (2005). Racial differences in opioid use for chronic nonmalignant pain. Journal of General Internal Medicine. 20(7). 593–598. 97 indexed citations
9.
Chen, Ian, James Kurz, Mark Pasanen, et al.. (2005). Racial differences in opioid use for chronic nonmalignant pain.. PubMed. 20(7). 593–8. 107 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026